These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9167946)

  • 1. Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms.
    Wynford-Thomas D
    Horm Res; 1997; 47(4-6):145-57. PubMed ID: 9167946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular basis of tumors arising in thyroid follicular cells].
    Wynford-Thomas D
    Ann Chir; 1999; 53(3):237-43. PubMed ID: 10339867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
    Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
    Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of thyroid nodules and cancer.
    Moretti F; Nanni S; Pontecorvi A
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):517-39. PubMed ID: 11289733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biology of thyroid neoplasms.
    Satta MA; Nanni S; Della Casa S; Pontecorvi A
    Rays; 2000; 25(2):151-61. PubMed ID: 11370534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of follicular cell derived thyroid cancers.
    Parameswaran R; Brooks S; Sadler GP
    Int J Surg; 2010; 8(3):186-93. PubMed ID: 20097316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rearrangements of NTRK1 oncogene in papillary thyroid carcinoma.
    Brzeziańska E; Pastuszak-Lewandoska D; Lewiński A
    Neuro Endocrinol Lett; 2007 Jun; 28(3):221-9. PubMed ID: 17627253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
    Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of epithelial thyroid tumorigenesis.
    Suarez HG
    C R Acad Sci III; 2000 Jun; 323(6):519-28. PubMed ID: 10923207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).
    Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
    Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
    Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
    Fagin JA; Matsuo K; Karmakar A; Chen DL; Tang SH; Koeffler HP
    J Clin Invest; 1993 Jan; 91(1):179-84. PubMed ID: 8423216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis.
    Wyllie FS; Lemoine NR; Williams ED; Wynford-Thomas D
    Br J Cancer; 1989 Oct; 60(4):561-5. PubMed ID: 2803926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro reconstruction of tumour initiation in a human epithelium.
    Bond JA; Wyllie FS; Rowson J; Radulescu A; Wynford-Thomas D
    Oncogene; 1994 Jan; 9(1):281-90. PubMed ID: 8302590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and pathogenesis of thyroid cancer in animals and man.
    Williams ED
    Mutat Res; 1995 Dec; 333(1-2):123-9. PubMed ID: 8538619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ras and gsp oncogenes in human epithelial thyroid tumorigenesis.
    Du Villard JA; Schlumberger M; Wicker R; Caillou B; Rochefort P; Feunteun J; Monier R; Parmentier C; Suarez HG
    J Endocrinol Invest; 1995 Feb; 18(2):124-6. PubMed ID: 7629378
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin.
    Motoi N; Sakamoto A; Yamochi T; Horiuchi H; Motoi T; Machinami R
    Pathol Res Pract; 2000; 196(1):1-7. PubMed ID: 10674266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas.
    Nibu K; Otsuki N; Nakao K; Sugasawa M; Rothstein JL
    Eur Arch Otorhinolaryngol; 2005 May; 262(5):368-73. PubMed ID: 15368067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.